Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $17.8500 (1.65%) ($17.8500 - $17.8500) on Tue. Apr. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.91% (three month average) | RSI | 51 | Latest Price | $17.8500(1.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(62%) IWC(61%) IBUY(60%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.455% in a week (0% probabilities). VIXM(-30%) UUP(-15%) VXX(-10%) TBT(-10%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.455% (StdDev 4.91%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $18.79 | 5 Day Moving Average | $18.51(-3.57%) | 10 Day Moving Average | $19.24(-7.22%) | 20 Day Moving Average | $18.79(-5%) | To recent high | -24.4% | To recent low | 26.6% | Market Cap | $1.109b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |